Relationship Between Lymphocyte Count and Risk Of Infection In Rheumatoid Arthritis Patients Treated With Tofacitinib

被引：0
作者：
Van Vollenhoven, R. F. [1 ]
Riese, R. [2 ]
Krishnaswami, S. [2 ]
Kawabata, T. [2 ]
Fosser, C. [2 ]
Rottinghaus, S. [2 ]
Lamba, M. [2 ]
Zwillich, S. H. [2 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Pfizer Inc, Groton, CT 06340 USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2330
引用
收藏
页码：S994 / S994
页数：1
相关论文
共 50 条
  • [1] RELATIONSHIP BETWEEN LYMPHOCYTE COUNT AND RISK OF INFECTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB
    van Vollenhoven, R.
    Riese, R.
    Krishnaswami, S.
    Kawabata, T.
    Fosser, C.
    Rottinghaus, S.
    Lamba, M.
    Zwillich, S. H.
    Bradley, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 250 - 251
  • [2] Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Valdez, Hernan
    Collinge, Mark
    Zwillich, Samuel H.
    Toyoizumi, Shigeyuki
    Kwok, Kenneth
    Hirose, Tomohiro
    MODERN RHEUMATOLOGY, 2024, 34 (06) : 1115 - 1124
  • [3] Monitoring of Absolute Lymphocyte Count in Patients with Rheumatoid Arthritis Treated with Tofacitinib
    Burmester, Gerd R.
    Szekanecz, Zoltan
    Biswas, Pinaki
    Krishnaswami, Sriram
    Mojcik, Christopher F.
    Valdez, Hernan
    Geier, Jamie
    Strengholt, Sander
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] RELATIONSHIP BETWEEN NK CELL COUNT AND IMPORTANT SAFETY EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB
    van Vollenhoven, R. F.
    Tanaka, Y.
    Lamba, M.
    Collinge, M.
    Hendrikx, T.
    Hirose, T.
    Toyoizumi, S.
    Hazra, A.
    Krishnaswami, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 258 - 259
  • [5] Relationship Between NK Cell Count and Important Safety Events in Rheumatoid Arthritis Patients Treated with Tofacitinib.
    van Vollenhoven, R.
    Tanaka, Y.
    Riese, R.
    Lamba, M.
    Kawabata, T.
    Hirose, T.
    Toyoizumi, S.
    Hazra, A.
    Krishnaswami, S.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S220 - S220
  • [6] Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis
    Isailovic, Natasa
    Ceribelli, Angela
    Cincinelli, Gilberto
    Vecellio, Matteo
    Guidelli, Giacomo
    Caprioli, Marta
    Luciano, Nicoletta
    Motta, Francesca
    Selmi, Carlo
    De Santis, Maria
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 205 (02) : 142 - 149
  • [7] Assessment of Lipid Changes and Infection Risk In Diabetic and Nondiabetic Patients With Rheumatoid Arthritis Treated With Tofacitinib
    Rigby, W. F. C.
    Takiya, L.
    Wood, S. P.
    Fan, H.
    Jones, T. V.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S995 - S995
  • [8] HAEMOGLOBIN CHANGES AND RELATIONSHIP BETWEEN ANAEMIA AND FATIGUE OR VITALITY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB
    Schulze-Koops, H.
    Benda, B.
    Wallenstein, G.
    Riese, R.
    Zwillich, S. H.
    Kwok, K.
    Wang, L.
    Bradley, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 246 - 247
  • [9] Neutrophil-lymphocyte ratio: an independent predictor of the herpes zoster risk in rheumatoid arthritis patients treated with tofacitinib
    Liu, Pengcheng
    Zhang, Min
    Zhang, Yueqin
    Yu, Shujiao
    Wu, Rui
    AKTUELLE RHEUMATOLOGIE, 2024,
  • [10] Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
    Myriam Riek
    Almut Scherer
    Burkhard Möller
    Adrian Ciurea
    Ines von Mühlenen
    Cem Gabay
    Diego Kyburz
    Laure Brulhart
    Johannes von Kempis
    Ruediger B. Mueller
    Paul Hasler
    Tanja Strahm
    Sabine von Känel
    Pascal Zufferey
    Jean Dudler
    Axel Finckh
    Scientific Reports, 13
12345